Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,429,019,361
-$74,670,130 QoQ
Shares Held
7,536,227
-1.2% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#29
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. AZN ranks #1 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,429,019,361 | 7,536,227 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,503,689,491 | 7,624,427 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||